CYTENA launches C.STATION, a fully automated platform for stable cell line development to streamline production of antibody and gene therapies

CYTENA is a part of BICO. Our products aim to reduce the
organ shortage and speed up drug development by
providing accessible life science solutions that combine
biology and technology, fundamentally shifting the global healthcare industry.